30mg tablets of Shire Plc's Adderall XR.JB Reed | Bloomberg | Getty Images Josh Disbrow is chairman and CEO of Aytu BioPharma, which makes a competing drug to treat ADHD called Adzenys XR-ODT. A nationwide shortage of Adderall has left many patients struggling to manage their attention deficit hyperactivity disorder, better known as ADHD. From all